Skip to main content

Table 2 Comorbidities on admission, divided for groups (DSG vs. NDSG)

From: COVID-19 inpatients with gastrointestinal onset: sex and care needs’ differences in the district of Ferrara, Italy

Comorbidity

DSG (N = 62)

NDSG (N = 433)

p value

Hypertension

41 (66.1)

265 (61.2)

0.52

Diabetes

19 (30.6)

89 (20.6)

0.07

Ischemic Heart Disease

5 (8.1)

58 (13.4)

0.23

Heart Failure

1 (1.6)

55 (12.7)

0.009

Chronic Kidney Disease (III-IV-V stage)

8 (12.9)

55 (12.7)

1.00

Stroke or TIA

9 (14.5)

52 (12.0)

0.84

PCOA

5 (8.1)

23 (5.3)

0.38

COPD

0 (0)

45 (10.4)

0.008

Hepatic Steatosis

3 (4.8)

9 (2.1)

0.19

End-stage Liver Disease

2 (3.2)

6 (1.4)

0.29

Localized or Hematological Cancer

15 (24.2)

70 (16.2)

0.13

Metastatic Cancer

6 (9.7)

21 (4.8)

0.12

  1. All data are expressed with number of cases (%)
  2. DGS Digestive Symptoms group, NDGS No Digestive Symptoms Group, TIA Transitory Ischemic Attack, PCOA Peripheral Chronic Obstructive Arteriopathy, COPD Chronic Obstructive Pulmonary Disease